Clinical Pharmacology & Biopharmaceutics
Open Access

Advancements in Print-and-Inject Technologies: Personalized Dosing and Targeted Drug Delivery for Chronic Disease Management

Md. Jasim Marques^*

Department of Pharmacy, BRAC University, Mohakhali, Bangladesh

Received Date: Nov 01, 2024 / Published Date: Nov 29, 2024

Citation: Jasim M (2024) Advancements in Print-and-Inject Technologies: Personalized Dosing and Targeted Drug Delivery for Chronic Disease Management Clin Pharmacol Biopharm, 13: 514.

Copyright: © 2024 Jasim M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article

Recent advancements in print-and-inject technologies are revolutionizing the landscape of personalized dosing and targeted drug delivery, offering promising solutions for the management of chronic diseases. These cutting-edge approaches allow for the creation of custom drug formulations and dosage regimens that can be tailored to the specific needs of individual patients. Print-and-inject systems, including 3D printing and microfluidic platforms, provide high precision in drug delivery, enabling more effective targeting of disease sites while minimizing systemic side effects. This innovation is poised to enhance patient outcomes by offering optimized treatment regimens, improving adherence, and reducing healthcare costs. Moreover, the integration of biomaterials and smart technologies, such as sensors and controlled release mechanisms, is further advancing the capability of these systems. This paper discusses the principles, recent developments, and future potential of print-and-inject technologies in chronic disease management, focusing on their application in personalized medicine